Catalyst Biosciences Inc to Acquire F351 Assets from GNI Group Ltd Call Transcript
Greetings. Welcome to the Catalyst Biosciences merger call. (Operator Instructions) Please note, this conference is being recorded. At this time, I'll turn the conference over to Monique Kosse, Investor Relations for Catalyst Biosciences. Monique, you may now begin.
Thank you, Rob. Good morning, everyone, and welcome to the Catalyst Biosciences conference call to discuss the first steps in its reverse merger plan as announced in a press release issued this morning. You may find a copy of that release and presentation on the company's website and in the SEC filings with -- and in the filings with the SEC. Joining me today from Catalyst is Dr. Nassim Usman, President and Chief Executive Officer; and Seline Miller, Interim CFO. After the prepared remarks, we will open the call for a Q&A session.
Before we begin, I would like to remind listeners that various remarks made on the call today contain forward-looking statements. These statements are subject to risks, uncertainties and other factors that could cause
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
